Skip to main content
Watch the video
8th annual conference session
SC-IN-01751 (March 2024)

Heart Failure association of India (HFAI) 8th annual conference session: Unveiling of Indian guideline on HFpEF management and Empagliflozin in treatment of HF across LVEF

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory.

Information Desk

For any therapeutic area or product related information please contact:
medical.query.mum@boehringer-ingelheim.com

In case you come across any adverse events related to our products, please connect with the Patient
Safety & Pharmacovigilance Team. 

Phone: +91 9819241697

Email: PV_local_India@boehringer-ingelheim.com